Navigation Links
New journal article urges use of animal serum-free media for growing live cells

In the March issue of Trends in Biotechnology, scientists and doctors with the Physicians Committee for Responsible Medicine (PCRM) recommend using only animal serum-free media to grow live cells in the laboratory. At issue is the use of fetal calf serum, which is obtained by puncturing the heart of a fetal calf without anesthesia. Recent breakthroughs permit the growth of human cells in a medium free of animal serum, enabling scientists and researchers to make cell culture safer and more humane.

"Scientists have access to humane and scientifically superior alternatives, so now is the time to completely eliminate the use of fetal calf serum in the laboratory," says Megha Shah Even, M.S., a staff scientist at PCRM and lead author of the paper. Live cells grown in the laboratory are used for many purposes including the manufacture of drugs and diagnostic kits.

Trends in Biotechnology, based in the United Kingdom, invited Mrs. Even to submit a paper after learning that she spearheaded the development of the world's first animal serum-free insulin assay. In addition to humane concerns, the article emphasizes the scientific advantages of serum-free cell culture. Growing cells without animal serum ensures that fewer variables are introduced into experiments, meaning that results are easily reproducible by different laboratories.


'"/>

Source:Physicians Committee for Responsible Medicine


Page: 1

Related biology news :

1. Open Access journals get impressive impact factors
2. Impressive new Impact Factors for BioMed Centrals open-access journals
3. Funding and bureaucracy, not access to journals, are chief obstacles to scientific productivity
4. Public Library of Science to launch new, open access journal on neglected tropical diseases
5. Are journal rankings distorting science?
6. DNA Molecules Used To Assemble Nanoparticles
7. Tiny particles could solve billion-dollar problem
8. Imaging Lymph Nodes with Nanoparticles
9. Taking Aim With Nanoparticle PEBBLEs
10. Probing The Promise And Perils Of Nanoparticles
11. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... -- Global demand for enzymes is forecast to grow ... billion.  This market includes enzymes used in industrial ... animal feed, and other markets) and specialty applications ... beverages will remain the largest market for enzymes, ... containing enzymes in developing regions.  These and other ...
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... mission to bring innovative medical technologies, services and solutions to the healthcare market. ... and implementation of various distribution, manufacturing, sales and marketing strategies that are necessary ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
Breaking Biology Technology: